Study of Complex Intracranial Aneurysm Treatment
- Conditions
- Intracranial Aneurysm
- Interventions
- Procedure: Cerebral RevascularizationProcedure: Endovascular Flow-Diversion
- Registration Number
- NCT03269942
- Lead Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Brief Summary
The investigator expects that endovascular flow-diversion is superior over revascularization by postoperative modified Rankin scale (mRS) in patients with complex intracranial aneurysms.
- Detailed Description
Open, prospective, controlled randomized superiority trial is conducted. The hypothesis is that endovascular flow-diversion is better than revascularization in treatment of complex intracranial aneurysms by postoperative modified Rankin Scale (mRS). Sample size was measured by Fisher exact test. Depending on a type of the procedure, the patients are divided into two groups: Endovascular Flow Diversion Procedure (include 55 patients) and Revascularization Procedure (include 55 patients). Randomization is performed by random number generation.The study was approved by Institutional Review Board
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 110
- anterior circulation complex intracranial aneurysm
- neck is more than 4 mm wide
- dome/neck ratio of aneurysm equals or less than 2:1
- age less than 75 years
- ability to give informed consent (subject or legally authorized representative)
- aneurysm is suitable for treatment to both procedures
- subarachnoid hemorrhage less than 30 days ago
- contraindications to endovascular treatment
- atypical aneurysms (mycotic, flow-related in patients with AVM, traumatic, false)
- informed consent refusal
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cerebral Revascularization Cerebral Revascularization Cerebral revascularization procedure with trapping of aneurysm Endovascular Flow-Diversion Endovascular Flow-Diversion Implantation of flow-diversion device
- Primary Outcome Measures
Name Time Method mRS 6, 12 months after procedure Change from baseline modified Rankin Scale
- Secondary Outcome Measures
Name Time Method Complete aneurysm occlusion 6, 12 months after procedure Measured as: complete occlusion or residual aneurysm (included neck remnant)
Major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm 6, 12 months after procedure
Trial Locations
- Locations (1)
Novosibirsk Research Institution of Circulation Pathology
🇷🇺Novosibirsk, Russian Federation